psychiatry
ASRS-v1.1 — Adult ADHD Self-Report Scale
WHO 6-item screener (Part A) for adult ADHD (Kessler 2005). Each item rated 0–4 (never to very often). Items 1–3 score 2+ and items 4–6 score 3+ are clinically significant ('darkened-box scoring'). This calc returns simple sum 0–24 — ≥4 darkened-box items strongly suggests ADHD.
References
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Drugs
- Atomoxetine · Selective Noradrenaline Reuptake Inhibitor (SNRI) — ADHD (Non-Stimulant)
- Sildenafil (Paediatric — PPHN / PAH) · PDE5 Inhibitor (Paediatric Pulmonary Hypertension)
- Methylphenidate · CNS Stimulant — Schedule 2 Controlled Drug (ADHD Treatment)
- Atomoxetine · Selective Noradrenaline Reuptake Inhibitor (SNRI) — Non-stimulant ADHD Treatment
- Lisdexamfetamine · CNS Stimulant (Prodrug) — Schedule 2 Controlled Drug (ADHD / Binge Eating Disorder)
- Guanfacine (Extended-Release) · Alpha-2A Adrenoceptor Agonist (ADHD — Non-Stimulant)
Pathways
- Acute Behavioural Disturbance / Rapid Tranquillisation · RCEM 2022; RCPsych 2022; NICE NG10
- Self-Harm Presentation · NICE NG225 (2022)
- Capacity Assessment (Mental Capacity Act) · MCA 2005; Code of Practice
- Acute Psychosis Management · NICE CG178 2014
- Depression Management · NICE CG90 2022
- Lithium Therapy Monitoring · NICE CG185 / BNF
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.